Axiflow is a biotechnology company focused on building specialized materials and assemblies used by the biopharmaceutical and diagnostics industry. Our first product in market launched in February was the diagnostic membrane used in Covid-19 rapid test kits, and we are supplying this membrane to companies across South Korea and China. We are looking to scale-up this solution in coming months. We are also engaged in R&D of single-use bioreactors and its single-use disposable assemblies, used extensively in manufacturing of vaccines and bio-therapeutics. We hope to launch this solution commercially by April-2023 with the help of external investors.